FDA: 580,000 prazosin bottles recalled for nitrosamines

The FDA says Teva Pharmaceuticals USA and Amerisource Health Services voluntarily recalled more than 580,000 bottles of prazosin hydrochloride capsules nationwide earlier this month due to potential nitrosamine impurities, which are considered possibly cancer‑causing. The agency classified the affected lots as Class II risk; prazosin is used to treat high blood pressure and sometimes PTSD‑related nightmares, and Twin Cities patients are advised to check their medication and consult pharmacists or physicians.